View in EDS

PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.

Saved in:
Bibliographic Details
Title: PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.
Authors: Reed DR; Johns Hopkins All Children's Hospital, St. Petersburg, FL.; Moffitt Cancer Center, Tampa, FL., Janeway KA; Boston Children's Hospital, Boston, MA., Minard CG; Baylor College of Medicine, Houston, TX., Hall D; Children's Oncology Group, Monrovia, CA., Crompton BD; Dana-Farber cancer institute, Boston, MA., Lazar AJ; Anderson Cancer Center, Houston, TX., Wang WL; Anderson Cancer Center, Houston, TX., Zylber R; NYP/Columbia University Medical Center, New York, NY., Contreras A; Anderson Cancer Center, Houston, TX., Carrero G; Nicklaus Children's Hospital, Miami, FL., Voss SD; Dana-Farber cancer institute, Boston, MA., Reid JM; Mayo Clinic, Rochester, MN., Safgren SL; Mayo Clinic, Rochester, MN., Militano O; Children's Oncology Group, Monrovia, CA., Gorlick R; Anderson Cancer Center, Houston, TX., Pickett CA; National Cancer Institute, Bethesda, MD., Fox E; St Jude Children's Research Hospital, TN., Weigel BJ; University of Minnesota, Minneapolis, MN.
Source: JCO oncology advances [JCO Oncol Adv] 2025; Vol. 2. Date of Electronic Publication: 2025 Oct 14.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9918956761606676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2994-9750 (Electronic) Linking ISSN: 29949750 NLM ISO Abbreviation: JCO Oncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42131734
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reed+DR%22">Reed DR</searchLink>; Johns Hopkins All Children's Hospital, St. Petersburg, FL.; Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Janeway+KA%22">Janeway KA</searchLink>; Boston Children's Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Minard+CG%22">Minard CG</searchLink>; Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Hall+D%22">Hall D</searchLink>; Children's Oncology Group, Monrovia, CA.<br /><searchLink fieldCode="AU" term="%22Crompton+BD%22">Crompton BD</searchLink>; Dana-Farber cancer institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Wang+WL%22">Wang WL</searchLink>; Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Zylber+R%22">Zylber R</searchLink>; NYP/Columbia University Medical Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Contreras+A%22">Contreras A</searchLink>; Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Carrero+G%22">Carrero G</searchLink>; Nicklaus Children's Hospital, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Voss+SD%22">Voss SD</searchLink>; Dana-Farber cancer institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Reid+JM%22">Reid JM</searchLink>; Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Safgren+SL%22">Safgren SL</searchLink>; Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Militano+O%22">Militano O</searchLink>; Children's Oncology Group, Monrovia, CA.<br /><searchLink fieldCode="AU" term="%22Gorlick+R%22">Gorlick R</searchLink>; Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Pickett+CA%22">Pickett CA</searchLink>; National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Fox+E%22">Fox E</searchLink>; St Jude Children's Research Hospital, TN.<br /><searchLink fieldCode="AU" term="%22Weigel+BJ%22">Weigel BJ</searchLink>; University of Minnesota, Minneapolis, MN.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918956761606676%22">JCO oncology advances</searchLink> [JCO Oncol Adv] 2025; Vol. 2. <i>Date of Electronic Publication: </i>2025 Oct 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%22">Wolters Kluwer Health </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918956761606676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2994-9750 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229949750%22">29949750 </searchLink><i>NLM ISO Abbreviation: </i>JCO Oncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42131734
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/oa-25-00094
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reed DR
      – PersonEntity:
          Name:
            NameFull: Janeway KA
      – PersonEntity:
          Name:
            NameFull: Minard CG
      – PersonEntity:
          Name:
            NameFull: Hall D
      – PersonEntity:
          Name:
            NameFull: Crompton BD
      – PersonEntity:
          Name:
            NameFull: Lazar AJ
      – PersonEntity:
          Name:
            NameFull: Wang WL
      – PersonEntity:
          Name:
            NameFull: Zylber R
      – PersonEntity:
          Name:
            NameFull: Contreras A
      – PersonEntity:
          Name:
            NameFull: Carrero G
      – PersonEntity:
          Name:
            NameFull: Voss SD
      – PersonEntity:
          Name:
            NameFull: Reid JM
      – PersonEntity:
          Name:
            NameFull: Safgren SL
      – PersonEntity:
          Name:
            NameFull: Militano O
      – PersonEntity:
          Name:
            NameFull: Gorlick R
      – PersonEntity:
          Name:
            NameFull: Pickett CA
      – PersonEntity:
          Name:
            NameFull: Fox E
      – PersonEntity:
          Name:
            NameFull: Weigel BJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2994-9750
          Numbering:
            – Type: volume
              Value: 2
          Titles:
            – TitleFull: JCO oncology advances
              Type: main
ResultId 1